Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease
Authors not listed
Duke University · 2018
Abstract
The purpose of this study is gain a better understanding of a molecule called alpha melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease. Alpha MSH has been shown to have an important role in the regulation of ocular immunity in animal models of inflammatory retinal diseases and retinal dystrophies, and there may be a protective effect of alpha MSH. By studying the levels of alpha MSH in your eye we may better understand its role in advanced dry macular degeneration. By studying the levels of this molecule we hope to better understand if it may be a good target for future treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2018). The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease. <em>Duke University</em>. https://clinicaltrials.gov/study/NCT03451578
Vancouver
Anonymous. The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease. Duke University. 2018.
BibTeX
@misc{anon2018TheRol,
title = {The Role of Alpha Melanocyte Stimulating Hormone in Ocular Disease},
author = {Anonymous},
journal = {Duke University},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Genetics 2017
Preprint · OA
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
Clinical Interventions in Aging 2008
Open access · CC-BY
Age-related macular degeneration and the aging eye
PubMed 1996
Preprint
Oral zinc and the second eye in age-related macular degeneration.
Universitas Indonesia 2019
Open access · US-GOV
Association of Protein Intake With Sarcopenia Among Institutionalized Elderly
GeroScience 2026
Citation only
Association of systemic aging and frailty with retinal alterations: insights from an integrated exposome and metabolome framework
Samsung Bioepis Co., Ltd. 2023
Open access · US-GOV